Cargando…
Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs
Since the first Hodgkin and Huxley ion channel model was described in the 1950s, there has been an explosion in mathematical models to describe ion channel function. As experimental data has become richer, models have concomitantly been improved to better represent ion channel kinetic processes, alt...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786197/ https://www.ncbi.nlm.nih.gov/pubmed/26963710 http://dx.doi.org/10.1371/journal.pone.0150761 |
_version_ | 1782420511787057152 |
---|---|
author | Moreno, Jonathan D. Lewis, Timothy J. Clancy, Colleen E. |
author_facet | Moreno, Jonathan D. Lewis, Timothy J. Clancy, Colleen E. |
author_sort | Moreno, Jonathan D. |
collection | PubMed |
description | Since the first Hodgkin and Huxley ion channel model was described in the 1950s, there has been an explosion in mathematical models to describe ion channel function. As experimental data has become richer, models have concomitantly been improved to better represent ion channel kinetic processes, although these improvements have generally resulted in more model complexity and an increase in the number of parameters necessary to populate the models. Models have also been developed to explicitly model drug interactions with ion channels. Recent models of drug-channel interactions account for the discrete kinetics of drug interaction with distinct ion channel state conformations, as it has become clear that such interactions underlie complex emergent kinetics such as use-dependent block. Here, we describe an approach for developing a model for ion channel drug interactions. The method describes the process of extracting rate constants from experimental electrophysiological function data to use as initial conditions for the model parameters. We then describe implementation of a parameter optimization method to refine the model rate constants describing ion channel drug kinetics. The algorithm takes advantage of readily available parallel computing tools to speed up the optimization. Finally, we describe some potential applications of the platform including the potential for gaining fundamental mechanistic insights into ion channel function and applications to in silico drug screening and development. |
format | Online Article Text |
id | pubmed-4786197 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-47861972016-03-23 Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs Moreno, Jonathan D. Lewis, Timothy J. Clancy, Colleen E. PLoS One Research Article Since the first Hodgkin and Huxley ion channel model was described in the 1950s, there has been an explosion in mathematical models to describe ion channel function. As experimental data has become richer, models have concomitantly been improved to better represent ion channel kinetic processes, although these improvements have generally resulted in more model complexity and an increase in the number of parameters necessary to populate the models. Models have also been developed to explicitly model drug interactions with ion channels. Recent models of drug-channel interactions account for the discrete kinetics of drug interaction with distinct ion channel state conformations, as it has become clear that such interactions underlie complex emergent kinetics such as use-dependent block. Here, we describe an approach for developing a model for ion channel drug interactions. The method describes the process of extracting rate constants from experimental electrophysiological function data to use as initial conditions for the model parameters. We then describe implementation of a parameter optimization method to refine the model rate constants describing ion channel drug kinetics. The algorithm takes advantage of readily available parallel computing tools to speed up the optimization. Finally, we describe some potential applications of the platform including the potential for gaining fundamental mechanistic insights into ion channel function and applications to in silico drug screening and development. Public Library of Science 2016-03-10 /pmc/articles/PMC4786197/ /pubmed/26963710 http://dx.doi.org/10.1371/journal.pone.0150761 Text en © 2016 Moreno et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Moreno, Jonathan D. Lewis, Timothy J. Clancy, Colleen E. Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs |
title | Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs |
title_full | Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs |
title_fullStr | Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs |
title_full_unstemmed | Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs |
title_short | Parameterization for In-Silico Modeling of Ion Channel Interactions with Drugs |
title_sort | parameterization for in-silico modeling of ion channel interactions with drugs |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786197/ https://www.ncbi.nlm.nih.gov/pubmed/26963710 http://dx.doi.org/10.1371/journal.pone.0150761 |
work_keys_str_mv | AT morenojonathand parameterizationforinsilicomodelingofionchannelinteractionswithdrugs AT lewistimothyj parameterizationforinsilicomodelingofionchannelinteractionswithdrugs AT clancycolleene parameterizationforinsilicomodelingofionchannelinteractionswithdrugs |